• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

线粒体ROS-氧化还原调节剂KH176在利氏病哺乳动物模型中的治疗作用

Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.

作者信息

de Haas Ria, Das Devashish, Garanto Alejandro, Renkema Herma G, Greupink Rick, van den Broek Petra, Pertijs Jeanne, Collin Rob W J, Willems Peter, Beyrath Julien, Heerschap Arend, Russel Frans G, Smeitink Jan A

机构信息

Department of Pediatrics, Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

Department of Pharmacology and Toxicology, Radboud Center for Mitochondrial Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.

出版信息

Sci Rep. 2017 Sep 15;7(1):11733. doi: 10.1038/s41598-017-09417-5.

DOI:10.1038/s41598-017-09417-5
PMID:28916769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5601915/
Abstract

Leigh Disease is a progressive neurometabolic disorder for which a clinical effective treatment is currently still lacking. Here, we report on the therapeutic efficacy of KH176, a new chemical entity derivative of Trolox, in Ndufs4 mice, a mammalian model for Leigh Disease. Using in vivo brain diffusion tensor imaging, we show a loss of brain microstructural coherence in Ndufs4 mice in the cerebral cortex, external capsule and cerebral peduncle. These findings are in line with the white matter diffusivity changes described in mitochondrial disease patients. Long-term KH176 treatment retained brain microstructural coherence in the external capsule in Ndufs4 mice and normalized the increased lipid peroxidation in this area and the cerebral cortex. Furthermore, KH176 treatment was able to significantly improve rotarod and gait performance and reduced the degeneration of retinal ganglion cells in Ndufs4 mice. These in vivo findings show that further development of KH176 as a potential treatment for mitochondrial disorders is worthwhile to pursue. Clinical trial studies to explore the potency, safety and efficacy of KH176 are ongoing.

摘要

Leigh病是一种进行性神经代谢障碍疾病,目前仍缺乏临床有效的治疗方法。在此,我们报告了一种新的化学实体——Trolox衍生物KH176,在Ndufs4小鼠(一种Leigh病的哺乳动物模型)中的治疗效果。通过体内脑扩散张量成像,我们发现Ndufs4小鼠的大脑皮层、外囊和脑桥中脑微结构连贯性丧失。这些发现与线粒体疾病患者中描述的白质扩散率变化一致。长期使用KH176治疗可使Ndufs4小鼠外囊中的脑微结构连贯性得以保留,并使该区域和大脑皮层中增加的脂质过氧化恢复正常。此外,KH176治疗能够显著改善Ndufs4小鼠的转棒试验和步态表现,并减少视网膜神经节细胞的退化。这些体内研究结果表明,将KH176进一步开发为线粒体疾病的潜在治疗方法是值得探索的。目前正在进行临床试验研究,以探究KH176的效力、安全性和疗效。

相似文献

1
Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease.线粒体ROS-氧化还原调节剂KH176在利氏病哺乳动物模型中的治疗作用
Sci Rep. 2017 Sep 15;7(1):11733. doi: 10.1038/s41598-017-09417-5.
2
Effects of clofibrate and KH176 on life span and motor function in mitochondrial complex I-deficient mice.氯贝丁酯和 KH176 对线粒体复合体 I 缺陷小鼠寿命和运动功能的影响。
Biochim Biophys Acta Mol Basis Dis. 2020 Jun 1;1866(6):165727. doi: 10.1016/j.bbadis.2020.165727. Epub 2020 Feb 15.
3
KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery.KH176 通过与硫氧还蛋白系统/过氧化物酶酶机制相互作用,保护线粒体病变细胞免受氧化应激诱导的细胞死亡。
Sci Rep. 2018 Apr 26;8(1):6577. doi: 10.1038/s41598-018-24900-3.
4
PKC downregulation upon rapamycin treatment attenuates mitochondrial disease.雷帕霉素处理后 PKC 的下调可减轻线粒体疾病。
Nat Metab. 2020 Dec;2(12):1472-1481. doi: 10.1038/s42255-020-00319-x. Epub 2020 Dec 14.
5
Targeting NAD Metabolism as Interventions for Mitochondrial Disease.靶向 NAD 代谢作为线粒体疾病的干预措施。
Sci Rep. 2019 Feb 28;9(1):3073. doi: 10.1038/s41598-019-39419-4.
6
Hypoxia ameliorates brain hyperoxia and NAD deficiency in a murine model of Leigh syndrome.缺氧改善 Leigh 综合征小鼠模型中的脑高氧和 NAD 缺乏。
Mol Genet Metab. 2021 May;133(1):83-93. doi: 10.1016/j.ymgme.2021.03.005. Epub 2021 Mar 11.
7
Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.Ndufs4 基因敲除 Leigh 综合征小鼠模型:发病机制与干预。
Brain. 2022 Mar 29;145(1):45-63. doi: 10.1093/brain/awab426.
8
Gait analysis in a mouse model resembling Leigh disease.在一种类似 Leigh 病的小鼠模型中的步态分析。
Behav Brain Res. 2016 Jan 1;296:191-198. doi: 10.1016/j.bbr.2015.09.006. Epub 2015 Sep 9.
9
mTOR inhibition alleviates mitochondrial disease in a mouse model of Leigh syndrome.mTOR 抑制缓解 Leigh 综合征小鼠模型中的线粒体疾病。
Science. 2013 Dec 20;342(6165):1524-8. doi: 10.1126/science.1244360. Epub 2013 Nov 14.
10
Acarbose suppresses symptoms of mitochondrial disease in a mouse model of Leigh syndrome.阿卡波糖可抑制 Leigh 综合征小鼠模型中线粒体疾病的症状。
Nat Metab. 2023 Jun;5(6):955-967. doi: 10.1038/s42255-023-00815-w. Epub 2023 Jun 26.

引用本文的文献

1
Mitochondrial diseases: from molecular mechanisms to therapeutic advances.线粒体疾病:从分子机制到治疗进展
Signal Transduct Target Ther. 2025 Jan 10;10(1):9. doi: 10.1038/s41392-024-02044-3.
2
Phase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation.针对因m.3243A>G突变导致线粒体疾病患者开展的司尼铬醇2b期项目。
Brain. 2025 Mar 6;148(3):896-907. doi: 10.1093/brain/awae277.
3
Mitochondrial Chronic Progressive External Ophthalmoplegia.线粒体慢性进行性眼外肌麻痹

本文引用的文献

1
Hypoxia treatment reverses neurodegenerative disease in a mouse model of Leigh syndrome.缺氧治疗可逆转 Leigh 综合征小鼠模型的神经退行性疾病。
Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4241-E4250. doi: 10.1073/pnas.1621511114. Epub 2017 May 8.
2
Post onset, oral rapamycin treatment delays development of mitochondrial encephalopathy only at supramaximal doses.发病后,口服雷帕霉素治疗仅在超最大剂量时才会延迟线粒体脑病的发展。
Neuropharmacology. 2017 May 1;117:74-84. doi: 10.1016/j.neuropharm.2017.01.039. Epub 2017 Feb 1.
3
Bipolar cell reduction precedes retinal ganglion neuron loss in a complex 1 knockout mouse model.
Brain Sci. 2024 Jan 27;14(2):135. doi: 10.3390/brainsci14020135.
4
Defective function of α-ketoglutarate dehydrogenase exacerbates mitochondrial ATP deficits during complex I deficiency.α-酮戊二酸脱氢酶功能缺陷加剧了复合物 I 缺陷时的线粒体 ATP 不足。
Redox Biol. 2023 Nov;67:102932. doi: 10.1016/j.redox.2023.102932. Epub 2023 Oct 17.
5
Recent advances in small molecules for improving mitochondrial disorders.用于改善线粒体疾病的小分子的最新进展。
RSC Adv. 2023 Jul 10;13(30):20476-20485. doi: 10.1039/d3ra03313a. eCollection 2023 Jul 7.
6
A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms ("KHENERGYC").一项随机安慰剂对照、双盲二期研究,旨在探索 sonlicromanol 在患有遗传性线粒体疾病和运动症状的儿童中的安全性、疗效和药代动力学(“KHENERGYC”)。
BMC Neurol. 2022 Apr 27;22(1):158. doi: 10.1186/s12883-022-02685-3.
7
Ndufs4 knockout mouse models of Leigh syndrome: pathophysiology and intervention.Ndufs4 基因敲除 Leigh 综合征小鼠模型:发病机制与干预。
Brain. 2022 Mar 29;145(1):45-63. doi: 10.1093/brain/awab426.
8
On the dynamic and even reversible nature of Leigh syndrome: Lessons from human imaging and mouse models. Leigh 综合征的动态性甚至可逆转性:来自人体成像和小鼠模型的启示。
Curr Opin Neurobiol. 2022 Feb;72:80-90. doi: 10.1016/j.conb.2021.09.006. Epub 2021 Oct 14.
9
Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons.声铬罗莫烷可改善与 iPSC 衍生神经元中 m.3243A>G 异质型相关的神经元网络功能障碍和转录组变化。
Stem Cell Reports. 2021 Sep 14;16(9):2197-2212. doi: 10.1016/j.stemcr.2021.07.002. Epub 2021 Jul 29.
10
Sonlicromanol's active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth.超声激活的前列腺癌干细胞 mPGES-1 小分子抑制剂 KH176m 通过抑制前列腺癌细胞球生长抑制肿瘤发生。
PLoS One. 2021 Jul 9;16(7):e0254315. doi: 10.1371/journal.pone.0254315. eCollection 2021.
在复合1基因敲除小鼠模型中,双极细胞减少先于视网膜神经节神经元丧失。
Brain Res. 2017 Feb 15;1657:232-244. doi: 10.1016/j.brainres.2016.12.019. Epub 2016 Dec 24.
4
The Assembly Pathway of Mitochondrial Respiratory Chain Complex I.线粒体呼吸链复合物 I 的组装途径。
Cell Metab. 2017 Jan 10;25(1):128-139. doi: 10.1016/j.cmet.2016.09.002. Epub 2016 Oct 6.
5
Corticostriatal circuitry.皮质纹状体回路
Dialogues Clin Neurosci. 2016 Mar;18(1):7-21. doi: 10.31887/DCNS.2016.18.1/shaber.
6
Mitochondrial disorders in children: toward development of small-molecule treatment strategies.儿童线粒体疾病:小分子治疗策略的发展方向
EMBO Mol Med. 2016 Apr 1;8(4):311-27. doi: 10.15252/emmm.201506131.
7
Hypoxia as a therapy for mitochondrial disease.缺氧作为线粒体疾病的一种治疗方法。
Science. 2016 Apr 1;352(6281):54-61. doi: 10.1126/science.aad9642. Epub 2016 Feb 25.
8
Region-Specific Defects of Respiratory Capacities in the Ndufs4(KO) Mouse Brain.Ndufs4基因敲除(KO)小鼠脑内呼吸能力的区域特异性缺陷
PLoS One. 2016 Jan 29;11(1):e0148219. doi: 10.1371/journal.pone.0148219. eCollection 2016.
9
The neuroimaging of Leigh syndrome: case series and review of the literature.Leigh综合征的神经影像学:病例系列及文献综述
Pediatr Radiol. 2016 Apr;46(4):443-51. doi: 10.1007/s00247-015-3523-5. Epub 2016 Jan 6.
10
Loss of the smallest subunit of cytochrome c oxidase, COX8A, causes Leigh-like syndrome and epilepsy.细胞色素 c 氧化酶最小亚基 COX8A 的缺失导致 Leigh 样综合征和癫痫。
Brain. 2016 Feb;139(Pt 2):338-45. doi: 10.1093/brain/awv357. Epub 2015 Dec 17.